Sign in to view content

Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial

Peter A. Campochiaro, MD

Video
Published 2021

Related

Episode 29: Anti-VEGF Levels in Breast Milk after Intravitreal Injections- Drs. Muni and Juncal
Keyvan Koushan, MD, FRCSC
Member Podcasts
Wet AMD 1 Symposium
Annual Meeting Talks
2020
Potential Safety Concerns of Bevacizumab
Robert L. Avery, MD
Updates from the Field
2017

Category: Pharmacology

See more